| Clinical pharmacokinetics of fluconazole D Debruyne, JP Ryckelynck Clinical pharmacokinetics 24 (1), 10-27, 1993 | 315 | 1993 |
| Focus on cannabinoids and synthetic cannabinoids R Le Boisselier, J Alexandre, V Lelong‐Boulouard, D Debruyne Clinical Pharmacology & Therapeutics 101 (2), 220-229, 2017 | 183 | 2017 |
| Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses D Debruyne Clinical pharmacokinetics 33, 52-77, 1997 | 177 | 1997 |
| Emerging drugs of abuse: current perspectives on substituted cathinones M Paillet-Loilier, A Cesbron, R Le Boisselier, J Bourgine, D Debruyne Substance abuse and rehabilitation, 37-52, 2014 | 138 | 2014 |
| Emerging drugs of abuse: current perspectives on synthetic cannabinoids D Debruyne, R Le Boisselier Substance abuse and rehabilitation, 113-129, 2015 | 133 | 2015 |
| Pharmacokinetics of antifungal agents in onychomycoses D Debruyne, A Coquerel Clinical pharmacokinetics 40, 441-472, 2001 | 121 | 2001 |
| Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis L Peyro Saint Paul, D Debruyne, D Bernard, DM Mock, GL Defer Expert opinion on drug metabolism & toxicology 12 (3), 327-344, 2016 | 116 | 2016 |
| Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat F Le Doze, D Debruyne, F Albessard, L Barre, GL Defer Drug metabolism and disposition 28 (2), 205-208, 2000 | 81 | 2000 |
| Substantial rise in sparteine metabolic ratio during haloperidol treatment. LF Gram, D Debruyne, V Caillard, JP Boulenger, J Lacotte, M Moulin, ... British journal of clinical pharmacology 27 (2), 272-275, 1989 | 72 | 1989 |
| Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion D Debruyne, BH de Ligny, JP Ryckelynck, F Albessard, M Moulin Clinical pharmacokinetics 12, 214-221, 1987 | 62 | 1987 |
| PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development F Sobrio, G Gilbert, C Perrio, L Barre, D Debruyne Mini reviews in medicinal chemistry 10 (9), 870-886, 2010 | 57 | 2010 |
| Toxicity and death following recreational use of 2-pyrrolidino valerophenone C Eiden, O Mathieu, P Cathala, D Debruyne, E Baccino, P Petit, ... Clinical toxicology 51 (9), 899-903, 2013 | 53 | 2013 |
| Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector D Debruyne, JP Ryckelynck, MC Bigot, M Moulin Journal of pharmaceutical sciences 77 (6), 534-535, 1988 | 52 | 1988 |
| Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis D Debruyne, JP Ryckelynck, M Moulin, BH de Ligny, B Levaltier, MC Bigot Clinical pharmacokinetics 18, 491-498, 1990 | 51 | 1990 |
| Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission … D Debruyne, P Abadie, L Barre, F Albessard, M Moulin, E Zarlfian, ... European journal of drug metabolism and pharmacokinetics 16, 141-152, 1991 | 45 | 1991 |
| Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced µ-opioid receptor regulation G Poisnel, M Dhilly, R Le Boisselier, L Barre, D Debruyne Journal of pharmacological sciences 110 (1), 36-46, 2009 | 44 | 2009 |
| Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation D Debruyne, F Sobrio, A Hinschberger, R Camsonne, A Coquerel, ... Journal of pharmaceutical sciences 92 (5), 1051-1057, 2003 | 44 | 2003 |
| New synthetic drugs in addictovigilance F Chavant, A Boucher, R Le Boisselier, S Deheul, D Debruyne Therapies 70 (2), 179-189, 2015 | 43 | 2015 |
| Comparison of three advanced chromatographic techniques for cannabis identification D Debruyne, F Albessard, MC Bigot, M Moulin Bull Narc 46 (2), 109, 1994 | 41 | 1994 |
| Determination of zolpidem and zopiclone in serum by capillary column gas chromatography D Debruyne, J Lacotte, BD Hurault Ligny, M Moulin Journal of pharmaceutical sciences 80 (1), 71-74, 1991 | 39 | 1991 |
